Deutsche Bank Ag\ Vista Gen Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.12 - $0.3 $19,743 - $49,358	164,527 Added 188.02%	252,033 $30,000
Q4 2022 Feb 13, 2023	SELL	$0.09 - $4.8 $21,752 - $1.16 Million	-241,699 Reduced 73.42%	87,506 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $32,199 - $1.1 Million	229,996 Added 231.83%	329,205 $50,000
Q2 2022 Aug 11, 2022	SELL	$0.88 - $1.73 $11,704 - $23,010	-13,301 Reduced 11.82%	99,209 $87,000
Q1 2022 May 13, 2022	SELL	$1.14 - $2.09 $14,262 - $26,147	-12,511 Reduced 10.01%	112,510 $140,000
Q4 2021 Feb 11, 2022	BUY	$1.67 - $2.76 $10,397 - $17,183	6,226 Added 5.24%	125,021 $244,000
Q3 2021 Nov 04, 2021	SELL	$2.62 - $3.45 $177,746 - $234,054	-67,842 Reduced 36.35%	118,795 $326,000
Q2 2021 Aug 11, 2021	BUY	$1.96 - $3.15 $365,808 - $587,906	186,637 New	186,637 $588,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.